| Home | | | Expert Login | | | Blog | | | FAQs | | | Newsletter | | | Contact Us |


Investigational New Drug (IND) |
877-838-8464 |
Definition: IND is the pharmaceutical research status of a drug being developed that has been approved for clinical investigation. | |
Featured
Investigational New Drug (IND)
Case Studies
|
Featured
Investigational New Drug (IND) Experts |
||||||||||||
|
Biotechnology Expert in Clinical Trials A biotechnology expert with knowledge of FDA clinical trials and procedures was requested for an arbitration case involving biotherapeutics. Pharmaceutical Development Expert with FDA Approval Experience A pharmaceutical development expert was sought for a misappropriation of trade secrets claim against the Food and Drug Administration. Pharmaceutical Sales Experts in Drug Labeling and Marketing A pharmaceutical sales expert was needed to evaluate the marketing claims of competing pharmaceutical manufacturing companies. |
|
||||||||||||
We are the premier expert provider in the industry -- not a directory of self-proclaimed experts. IMS is the only firm that does a proactive, custom search based on your specific case needs.
For more information about our expert witness process, or to speak to a representative now about any of our expert witness and litigation consultant search services, contact IMS ExpertServices or call 877.838.8464.